— Know what they know.
Not Investment Advice

NTHI NASDAQ

Neonc Technologies Holdings, Inc.
1W: +8.3% 1M: -5.1% 3M: -14.3% YTD: -66.2% 1Y: -66.1%
$3.00
+0.18 (+6.38%)
 
Weekly Expected Move ±12.5%
$2 $3 $3 $4 $4
NASDAQ · Healthcare · Biotechnology · Tech Score Sell · Power 34 · $86.4M mcap · 6M float · 2.71% daily turnover · Short 68% of daily vol
Credit Risk of going bust: lower than 56% of companies Debt: 0.4% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the middle of the pack, about 1 in 580 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.00 (down more than 99.9%), Neonc Technologies Holdings, Inc. would be worth roughly what it owes.
Total debt $328K against a stock market value of $86.4M.
Distance to default 5.79 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $74K (short-term plus half of long-term), stock volatility 112.0%; Altman Z'' -166.82. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.

Supply Chain Overview

9 relationships
9
As Filer
counterparties named
0
As Counterparty
mentioned by others
4
Rel. Types
2025-04-11
Earliest Filing
2025-10-09
Latest Filing
partner: 5 target: 2 supplier: 1 investor: 1

Counterparties (Filed by NTHI)

9 relationships

Companies named in NTHI's SEC 8-K filings as business counterparties.

Counterparty Ticker Relationship Summary Filing Date SEC
Insights Pharmaceutical Research LLC — supplier Contract research organization providing clinical research services for UAE trials 2025-10-09 View
Group 42 Holding Ltd — partner Affiliate of IROS 2025-10-09 View
Mubadala Investment Company PJSC — partner Affiliate of IROS 2025-10-09 View
NuroCure — partner Company's controlled UAE subsidiary 2025-10-09 View
JandB Holdings, LLC — target Acquired 100% of membership interests in exchange for Company common stock. 2025-08-22 View
Quazar For Investment in Commercial Enterprises & Management LLC — investor Agreed to purchase 2.5M shares of NuroMENA and lead an additional $50M investment round. 2025-08-01 View
NuroMENA Holdings Ltd — target Wholly owned subsidiary of NeOnc Technologies Holdings, Inc. receiving investment from Quazar. 2025-08-01 View
RREF II Calabasas Park Center LLC — partner Entered into an office lease agreement for the Company's new principal executive offices. 2025-04-11 View
AFH Holdings and Advisory, LLC — partner Engaged as exclusive advisor for public listing, investor relations, and M&A activities. 2025-04-11 View
Recent 8-K Filings (20)
Filing Date Description Type SEC
2026-10-22 Regulation FD; Exhibits View
2026-10-15 Officer/Director Change; Regulation FD; Exhibits View
2026-09-28 Regulation FD; Exhibits View
2026-09-21 Bylaws Amendment; Regulation FD; Exhibits View
2026-09-17 Regulation FD; Exhibits View
2026-09-10 Material Agreement; Regulation FD; Exhibits Agreement View
2026-08-21 Officer/Director Change View
2026-08-20 Shareholder Vote View
2026-08-13 Regulation FD; Exhibits View
2026-08-12 Regulation FD; Exhibits View
2026-08-10 Earnings Release; Regulation FD; Exhibits View
2026-07-15 Regulation FD; Exhibits View
2026-07-02 Officer/Director Change View
2026-06-23 Regulation FD; Exhibits View
2026-06-18 Regulation FD; Exhibits View
2026-06-12 Material Agreement; Unregistered Equity Sales; Bylaws Amendment; Exhibits Agreement View
2026-05-18 Earnings Release; Regulation FD; Exhibits View
2026-04-24 Material Agreement; Unregistered Equity Sales; Exhibits Agreement View
2026-04-16 Regulation FD; Exhibits View
2026-04-10 Material Agreement; Exhibits Agreement View
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text. Covers 2021–2026. View on SEC EDGAR

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms